中国组织工程研究 ›› 2026, Vol. 30 ›› Issue (22): 5682-5693.doi: 10.12307/2026.141

• 肌肉肌腱韧带组织构建 tissue construction of the muscle, tendon and ligament • 上一篇    下一篇

骨疏康颗粒含药血清调节线粒体稳态改善地塞米松诱导的C2C12肌管细胞萎缩

魏  巍1,刘洪飞2,戚晓楠3,刘彦彤2,王德羽2,于智同2,乔春林1,王世轩1,滕  海1   

  1. 1辽宁中医药大学附属第二医院骨科,辽宁省沈阳市   110032;2 辽宁中医药大学,辽宁省沈阳市   110087;3 辽宁中医药大学附属医院骨一科,辽宁省沈阳市   110031

  • 收稿日期:2025-03-12 接受日期:2025-08-06 出版日期:2026-08-08 发布日期:2025-12-26
  • 通讯作者: 滕海,硕士,主任医师,辽宁中医药大学附属第二医院骨科,辽宁省沈阳市 110032
  • 作者简介:魏巍,男,1992年生,2022年辽宁中医药大学毕业,博士,主治医师,主要从事中医药治疗骨质疏松症、股骨头坏死的研究。
  • 基金资助:
    辽宁省教育厅面上项目(JYTMS20231832),项目负责人:魏巍;国家自然科学基金青年基金项目(82305275),项目负责人:戚晓楠;辽宁省科技厅博士科研启动基金计划项目(2023-BS-050),项目负责人:魏巍;国家中医药管理局全国名老中医药专家传承工作室:2022王世轩全国老中医药专家传承工作室建设项目[国中医药人教函(2022)75号],项目负责人:王世轩

Gushukang Granule-containing drug serum improves dexamethasone-induced atrophy of C2C12 myotubes via regulating mitochondrial homeostasis

Wei Wei1, Liu Hongfei2, Qi Xiaonan3, Liu Yantong2, Wang Deyu2, Yu Zhitong2, Qiao Chunlin1, Wang Shixuan1, Teng Hai1   

  1. 1Department of Orthopedics, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, Liaoning Province, China; 2Liaoning University of Traditional Chinese Medicine, Shenyang 110087, Liaoning Province, China; 3Department of Orthopedics 1, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110031, Liaoning Province, China
  • Received:2025-03-12 Accepted:2025-08-06 Online:2026-08-08 Published:2025-12-26
  • Contact: Teng Hai, MS, Chief physician, Department of Orthopedics, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, Liaoning Province, China
  • About author:Wei Wei, PhD, Attending physician, Department of Orthopedics, The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, Liaoning Province, China
  • Supported by:
    Liaoning Provincial Department of Education General Project, No. JYTMS20231832 (to WW); National Natural Science Foundation for the Youth, No. 82305275 (to QXN); Doctoral Research Initiation Fund Program Project of Liaoning Provincial Department of Science and Technology, No. 2023-BS-050 (to WW); National Administration of Traditional Chinese Medicine National Famous Elderly Chinese Medicine Expert Inheritance Workshop: 2022 Wang Shixuan National Elderly Chinese Medicine Expert Inheritance Workshop Construction Project, No. (2022)75 (to WSX) 

摘要:


文题释义:
肌管细胞萎缩:指的是肌管细胞出现形态、结构以及功能上的病理性改变,表现为细胞体积缩小、细胞内的细胞器数量减少、线粒体等关键结构发生萎缩或形态模糊不清等情况,同时细胞整体的生理功能也随之下降。在相关研究情境中,常因外界不良刺激[比如地塞米松、药物毒性(如顺铂等化疗药)、重金属暴露(如铅、汞)、电离辐射、紫外线、机械损伤以及病毒感染(如柯萨奇病毒)、细菌毒素(如破伤风毒素)]等引发,是反映肌肉组织损伤、肌肉功能退变等状况的一种细胞层面的表现,对于探究肌肉相关疾病的发病机制以及药物干预效果等有着重要的研究意义。
线粒体稳态:是指线粒体在细胞内维持相对稳定的状态,包括线粒体的形态、数量、功能以及线粒体内部的各种生理生化过程(如能量代谢、氧化还原平衡、物质运输等)处于一种动态平衡。

背景:骨疏康颗粒是一种中药复方制剂,临床上常用于治疗骨质疏松症等骨骼相关疾病,但它在调控肌肉代谢中的作用尚不明确。
目的:探究骨疏康颗粒含药血清对地塞米松诱导的C2C12肌细胞萎缩的抑制效果。
方法:①体内实验:选取3月龄雌性SD大鼠36只,随机分为3组,每组12只,模型组大鼠肌肉注射地塞米松(2.5 mg/kg),1次/d,连续给药1周,随后正常饲养3周;骨疏康组大鼠造模后灌胃0.48 g/kg骨疏康颗粒混悬液,1次/d,连续3周;空白组未造模,灌胃等量蒸馏水,1次/d,连续4周。末次给药2 h后,取左侧大鼠股骨及腓肠肌标本进行苏木精-伊红染色,提取右侧腓肠肌及股骨组织RNA,通过实时荧光定量PCR检测线粒体功能、自噬及炎症相关基因mRNA表达水平。②体外实验:培养C2C12细胞并用体积分数2%马血清诱导其分化为肌管细胞。将分化后的肌管细胞分为对照组、模型组和骨疏康含药血清组。通过4 µmol/L地塞米松孵育48 h构建肌肉萎缩模型,其中骨疏康组在地塞米松处理24 h后加入体积分数10%的骨疏康含药血清再干预24 h。CCK-8检测细胞活力,流式细胞术检测活性氧水平,透射电镜观察细胞超微结构变化;Western blot检测线粒体功能相关蛋白、自噬相关蛋白及抗氧化相关蛋白表达水平。
结果与结论:①苏木精-伊红染色显示,与模型组相比,骨疏康组大鼠肌肉纤维结构恢复较好;实时荧光定量PCR进一步验证了骨疏康颗粒对线粒体功能和自噬相关基因具有上调作用,支持其通过多靶点机制缓解肌肉萎缩。②流式细胞术和CCK-8结果显示,地塞米松处理后C2C12细胞活性氧水平显著升高(P < 0.05),细胞活力显著降低(P < 0.05);透射电镜观察发现地塞米松诱导细胞超微结构紊乱,细胞器数量明显减少,线粒体呈现萎缩模糊状态,并伴随大量自噬小体及细胞质空泡的出现;Western blot结果表明,地塞米松处理后线粒体功能相关蛋白线粒体外膜转位酶20、热休克蛋白60表达显著降低,自噬相关蛋白LC3和Beclin-1异常表达(P < 0.05),沉默信息调节因子1表达显著降低(P < 0.05),提示地塞米松破坏了线粒体稳态并抑制了自噬功能。经过骨疏康颗粒含药血清处理后,活性氧水平显著降低(P < 0.05),细胞活力显著升高(P < 0.05);透射电镜观察显示细胞超微结构有所改善,线粒体形态相对恢复;Western blot结果显示,线粒体外膜转位酶20、热休克蛋白60、沉默信息调节因子1的表达显著上调(P < 0.05),LC3和Beclin-1表达恢复至正常水平(P < 0.05),表明骨疏康颗粒含药血清在改善线粒体功能、降低氧化应激以及调控自噬方面发挥了积极作用。
https://orcid.org/0000-0002-7021-9310 (魏巍) 

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

关键词: C2C12细胞, 肌管细胞, 地塞米松, 骨疏康颗粒, 线粒体稳态, 含药血清, 肌肉减少症, 自噬小体

Abstract: BACKGROUND: Gushukang Granule is a Chinese herbal compound preparation, which is commonly used clinically for the treatment of osteoporosis and other bone-related diseases. However, its role in the regulation of muscle metabolism is not clear.
OBJECTIVE: To investigate the inhibitory effect of Gushukang Granule-containing serum on dexamethasone-induced C2C12 muscle atrophy.
METHODS: (1) In vivo experiment: Thirty-six 3-month-old female Sprague-Dawley rats were randomly divided into model group, blank group and Gushukang group, with 12 rats in each group. The rats in the model group were given 2.5 mg/kg dexamethasone by intragastric administration, once a day, for 1 week, followed by 3 weeks of normal feeding. The rats in the Gushukang group were given 0.48 g/kg Gushukang Granule suspension by intragastric administration after modeling, once a day, for 3 weeks. The rats in the blank group were given the same amount of distilled water by intragastric administration without modeling, once a day for 4 weeks. Two hours after the last administration, the left femur and gastrocnemius specimens of rats were taken and stained with hematoxylin-eosin to observe the morphological changes. At the same time, RNA was extracted from the right gastrocnemius and femur tissues, and the mRNA expression levels of mitochondrial function, autophagy and inflammatory genes were detected by real-time fluorescent quantitative PCR. (2) In vitro experiment: C2C12 cells were cultured and induced with 2% equine serum to differentiate into myotube cells. The differentiated myotube cells were divided into control group, model group and Gushukang Granule-containing serum group. The muscle atrophy model was constructed by incubation with 4 µmol/L dexamethasone for 48 hours, in which the Gushukang group was treated with dexamethasone for 24 hours followed by cultured with 10% Gushukang drug-containing serum for another 24 hours. Cell counting kit-8 was used to detect cell viability, flow cytometry was used to detect reactive oxygen species, and ultrastructural changes were observed by transmission electron microscopy. The expression levels of mitochondrial function related proteins, autophagy related proteins and antioxidant related proteins were detected by western blot.
RESULTS AND CONCLUSION: (1) Hematoxylin-eosin staining showed that compared with the model group, the muscle fiber structure recovered well in the Gushukang group. Real-time fluorescence quantitative PCR further verified the upregulatory effect of Gushukang Granule-containing serum on mitochondrial function and autophagy related genes, supporting its multi-target mechanism to alleviate muscle atrophy. (2) The results of flow cytometry and cell counting kit-8 showed that the reactive oxygen species level in C2C12 cells was significantly increased after dexamethasone treatment (P < 0.05), and the cell viability was significantly decreased (P < 0.05). Under the transmission electron microscopy, dexamethasone induced ultrastructure disorder, the number of organelles decreased significantly, and mitochondrial atrophy and fuzzy state appeared, accompanied by a large number of autophagosomes and cytoplasmic vacuoles. Western blot results showed that the expressions of mitochondrial function-related proteins (translocase of outer mitochondrial membrane 20 and heat shock protein 60) were significantly decreased after dexamethasone treatment, the autophagy related proteins (LC3 and Beclin-1) were abnormally expressed (P < 0.05), and the expression of silent information regulator 1 was significantly decreased (P < 0.05). It is suggested that dexamethasone can destroy mitochondrial homeostasis and inhibit autophagy. After treatment with drug-containing serum of Gushukang Granules, reactive oxygen species level was significantly decreased (P < 0.05), and cell viability was significantly increased (P < 0.05). Under the transmission electron microscopy, the ultrastructure of the cells was improved and the morphology of mitochondria was relatively restored, but not completely repaired. Western blot results further showed that the expressions of translocase of outer mitochondrial membrane 20, heat shock protein 60 and silent information regulator 1 were significantly up-regulated (P < 0.05), and the expressions of LC3 and Beclin-1 returned to normal levels (P < 0.05). These findings indicate that the drug-containing serum of Gushukang Granules plays a positive role in improving mitochondrial function, reducing oxidative stress and regulating autophagy.


Key words: C2C12 cells, myotube cells, dexamethasone, Gushukang Granules, mitochondrial homeostasis, drug-containing serum, sarcopenia, autophagosome

中图分类号: